[HTML][HTML] Toxicology and pharmacology of synthetic organoselenium compounds: An update
Here, we addressed the pharmacology and toxicology of synthetic organoselenium
compounds and some naturally occurring organoselenium amino acids. The use of …
compounds and some naturally occurring organoselenium amino acids. The use of …
[PDF][PDF] After a century of nisin research-where are we now?
D Field, M Fernandez de Ullivarri… - FEMS microbiology …, 2023 - academic.oup.com
It is almost a century since nisin was discovered in fermented milk cultures, coincidentally in
the same year that penicillin was first described. Over the last 100 years this small, highly …
the same year that penicillin was first described. Over the last 100 years this small, highly …
Considerations and caveats in combating ESKAPE pathogens against nosocomial infections
YX Ma, CY Wang, YY Li, J Li, QQ Wan… - Advanced …, 2020 - Wiley Online Library
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter …
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter …
[HTML][HTML] Ebselen and analogues: Pharmacological properties and synthetic strategies for their preparation
C Santi, C Scimmi, L Sancineto - Molecules, 2021 - mdpi.com
Ebselen is the leader of selenorganic compounds, and starting from its identification as
mimetic of the key antioxidant enzyme glutathione peroxidase, several papers have …
mimetic of the key antioxidant enzyme glutathione peroxidase, several papers have …
Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus
Vancomycin-resistant enterococci (VRE) are the second leading cause of hospital-acquired
infections (HAIs) attributed to a drug-resistant bacterium in the United States, and resistance …
infections (HAIs) attributed to a drug-resistant bacterium in the United States, and resistance …
Development and therapeutic potential of selenazo compounds
AC Ruberte, C Sanmartin, C Aydillo… - Journal of Medicinal …, 2019 - ACS Publications
Incorporation of selenium (Se) atom into small molecules can substantially enhance their
antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral …
antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral …
[HTML][HTML] Thioredoxin reductase is a valid target for antimicrobial therapeutic development against gram-positive bacteria
LO Felix, E Mylonakis, BB Fuchs - Frontiers in Microbiology, 2021 - frontiersin.org
There is a drought of new antibacterial compounds that exploit novel targets. Thioredoxin
reductase (TrxR) from the Gram-positive bacterial antioxidant thioredoxin system has …
reductase (TrxR) from the Gram-positive bacterial antioxidant thioredoxin system has …
Evaluation of 1, 3, 4-thiadiazole carbonic anhydrase inhibitors for gut decolonization of vancomycin-resistant enterococci
Vancomycin-resistant enterococci (VRE), Enterococcus faecium and Enterococcus faecalis,
are high-priority drug-resistant pathogens in need of new therapeutic approaches. VRE …
are high-priority drug-resistant pathogens in need of new therapeutic approaches. VRE …
In Vivo Antibacterial Activity of Acetazolamide
Vancomycin-resistant enterococci (VRE) represent a major public health threat that requires
the development of new therapeutics. In the present study, acetazolamide (AZM) was …
the development of new therapeutics. In the present study, acetazolamide (AZM) was …
Ebselen optimized the therapeutic effects of silver nanoparticles for periodontal treatment
Y Liang, B Wang, Q Yu, W Wang, S Ge… - International Journal of …, 2023 - Taylor & Francis
Objective Silver nanoparticles (AgNPs) possess excellent antibacterial effects on
periodontal pathogens, but their clinical application is limited mainly due to their cytotoxicity …
periodontal pathogens, but their clinical application is limited mainly due to their cytotoxicity …